CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 43 filers reported holding CHEMBIO DIAGNOSTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $80,000 | -25.9% | 22,832 | 0.0% | 0.00% | -25.0% |
Q4 2020 | $108,000 | -28.9% | 22,832 | -51.2% | 0.00% | -60.0% |
Q2 2020 | $152,000 | -59.7% | 46,745 | -36.5% | 0.01% | -67.7% |
Q1 2020 | $377,000 | -32.4% | 73,634 | -39.9% | 0.03% | -36.7% |
Q4 2019 | $558,000 | -19.5% | 122,461 | +8.1% | 0.05% | -23.4% |
Q3 2019 | $693,000 | +23.8% | 113,250 | +23.2% | 0.06% | +25.5% |
Q2 2019 | $560,000 | +50.9% | 91,908 | +37.6% | 0.05% | +41.7% |
Q1 2019 | $371,000 | +106.1% | 66,799 | +109.7% | 0.04% | +38.5% |
Q4 2018 | $180,000 | – | 31,850 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Penbrook Management LLC | 354,670 | $887,000 | 0.55% |
Newbridge Financial Services Group, Inc. | 61,675 | $154,000 | 0.10% |
GAGNON SECURITIES LLC | 47,793 | $119,000 | 0.02% |
Phocas Financial Corp. | 30,000 | $75,000 | 0.01% |
ROYCE & ASSOCIATES LP | 491,453 | $1,229,000 | 0.01% |
SEGALL BRYANT & HAMILL, LLC | 701,318 | $1,754,000 | 0.01% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 179,680 | $449,000 | 0.01% |
Jump Financial, LLC | 37,900 | $95,000 | 0.01% |
Cutler Group LLC / CA | 44,918 | $112,000 | 0.01% |
Virtu Financial LLC | 19,653 | $49,000 | 0.00% |